Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
May 15, 2014 (Vol. 34, No. 10)

Bioinformatics Software Packages

URL:bioinformaticstools.mayo.edu
  • Variety of free bioinformatics tools
  • Many tools not cross-platform

As a leading institution in medical training and clinical research, it is appropriate that the Mayo Clinic is also taking a leading role in the development of new bioinformatics tools for genomic data. The Bioinformatics Program at the Mayo Clinic has made its software packages freely available for academics on the Bioinformatics Software Packages website. There are currently 14 software packages available on the site. To briefly highlight a few, BIMA is a mapping/alignment tool designed for next-generation sequencing; ESNV-DETECT uses RNA-Seq data to identify sequence variants; and GENOMESMASHER allows users to create “diploid” FASTA sequence files containing genetic features such as indels and SNPs that can be used to test next-generation sequencing pipelines via in silico simulations. Site visitors should be aware that many of the tools require LINUX or a cluster environment.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »